apoligsen sodium (Fujian Kinsan Biopharmaceutical)

N/A

Report date: 2025/03/17 20:00:36
NME

Base Information

Drug Nameapoligsen sodium (Fujian Kinsan Biopharmaceutical)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide antisense
Mechanisms of ActionApoptosis regulator Bcl-2 modulators
TargetsApoptosis regulator Bcl-2
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFuzhou Jinshan Biological Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFuzhou Jinshan Biological Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A